De Keyser F - Search Results

1

Ankylosing spondylitis and bowel disease.

Baeten D, De Keyser F, Mielants H, Veys EM. Baeten D, et al. Among authors: de keyser f. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):537-49. doi: 10.1053/berh.2002.0249. Best Pract Res Clin Rheumatol. 2002. PMID: 12406426 Review.

2

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

Baeten D, Demetter P, Cuvelier CA, Kruithof E, Van Damme N, De Vos M, Veys EM, De Keyser F. Baeten D, et al. Among authors: de vos m, de keyser f. J Pathol. 2002 Mar;196(3):343-50. doi: 10.1002/path.1044. J Pathol. 2002. PMID: 11857499

3

Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).

VanderBorght A, De Keyser F, Geusens P, De Backer M, Malaise M, Baeten D, Van den Bosch F, Veys EM, Raus J, Stinissen P. VanderBorght A, et al. Among authors: de backer m, de keyser f. J Rheumatol. 2002 Mar;29(3):416-26. J Rheumatol. 2002. PMID: 11908552 Clinical Trial.

4

The cutting edge of spondylarthropathy research in the millennium.

Granfors K, Märker-Hermann E, de Keyser F, Khan MA, Veys EM, Yu DT. Granfors K, et al. Among authors: de keyser f. Arthritis Rheum. 2002 Mar;46(3):606-13. doi: 10.1002/art.10041. Arthritis Rheum. 2002. PMID: 11920395 Free article. Review. No abstract available.

5

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM. Van Den Bosch F, et al. Among authors: de keyser f. Arthritis Rheum. 2002 Mar;46(3):755-65. doi: 10.1002/art.511. Arthritis Rheum. 2002. PMID: 11920412 Free article. Clinical Trial.

6

Immune linkages between inflammatory bowel disease and spondyloarthropathies.

Baeten D, De Keyser F, Mielants H, Veys EM. Baeten D, et al. Among authors: de keyser f. Curr Opin Rheumatol. 2002 Jul;14(4):342-7. doi: 10.1097/00002281-200207000-00002. Curr Opin Rheumatol. 2002. PMID: 12118165 Review.

7

Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles.

Gu J, Rihl M, Märker-Hermann E, Baeten D, Kuipers JG, Song YW, Maksymowych WP, Burgos-Vargas R, Veys EM, De Keyser F, Deister H, Xiong M, Huang F, Tsai WC, Yu DT. Gu J, et al. Among authors: de keyser f. J Rheumatol. 2002 Oct;29(10):2159-64. J Rheumatol. 2002. PMID: 12375327

8

Gut inflammation and spondyloarthropathies.

De Keyser F, Baeten D, Van den Bosch F, De Vos M, Cuvelier C, Mielants H, Veys E. De Keyser F, et al. Among authors: de vos m. Curr Rheumatol Rep. 2002 Dec;4(6):525-32. doi: 10.1007/s11926-002-0061-6. Curr Rheumatol Rep. 2002. PMID: 12427369 Review.

9

Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.

Hoffman IE, Peene I, Veys EM, De Keyser F. Hoffman IE, et al. Among authors: de keyser f. Clin Chem. 2002 Dec;48(12):2171-6. Clin Chem. 2002. PMID: 12446473

10

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F. De Rycke L, et al. Among authors: de keyser f. Arthritis Rheum. 2003 Apr;48(4):1015-23. doi: 10.1002/art.10876. Arthritis Rheum. 2003. PMID: 12687543 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters